• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和恶性乳腺组织中的孕激素受体亚型

Progesterone receptor isoforms in normal and malignant breast.

作者信息

Mote P A, Graham J D, Clarke C L

机构信息

Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Darcy Rd, 2145 Westmead, Australia.

出版信息

Ernst Schering Found Symp Proc. 2007(1):77-107.

PMID:18540569
Abstract

Progesterone is an essential regulator of normal female reproductive function, yet recent studies on the use of progestins in hormone replacement therapy have clearly implicated progestins in breast cancer development, a disease initiated early in life at a time of frequent exposure to cycling ovarian hormones. The effects of progesterone are mediated by two distinct nuclear receptor proteins, PRA and PRB. In normal breast PRA and PRB are co-expressed at similar levels in luminal epithelial cells, suggesting that both proteins are required to mediate physiologically relevant progesterone signalling. However, early in breast carcinogenesis PRA:PRB expression is disrupted, resulting in frequent predominance of one isoform. Unbalanced expression of PRA and PRB results in altered hormonal response and aberrant targeting of genes that are not normally progestin-regulated, principally those involved in morphological changes and disruptions of the actin cytoskeleton, and in migration. Movement of PR into discrete nuclear domains, or foci, is a critical step in normal PR transcriptional activity that appears to be aberrant in cancers and likely related to alterations in nuclear morphology, gene expression and cell function associated with tumour cells. Given that exogenous progestins are consumed by millions of women worldwide in the form of hormone replacement therapy and oral contraceptives, it is vital to better understand the mechanisms of progesterone action in the breast.

摘要

孕酮是正常女性生殖功能的重要调节因子,但近期有关孕激素在激素替代疗法中应用的研究已明确表明,孕激素与乳腺癌的发生有关。乳腺癌是一种在生命早期、频繁暴露于周期性卵巢激素时就开始的疾病。孕酮的作用由两种不同的核受体蛋白PRA和PRB介导。在正常乳腺中,PRA和PRB在腔上皮细胞中以相似水平共表达,这表明两种蛋白都需要介导生理相关的孕酮信号传导。然而,在乳腺癌发生早期,PRA:PRB的表达被破坏,导致一种异构体频繁占主导。PRA和PRB的不平衡表达导致激素反应改变以及对正常情况下不受孕激素调节的基因的异常靶向,主要是那些参与形态变化、肌动蛋白细胞骨架破坏和迁移的基因。PR进入离散的核区域或核灶是正常PR转录活性的关键步骤,这在癌症中似乎是异常的,并且可能与肿瘤细胞相关的核形态、基因表达和细胞功能的改变有关。鉴于全球数百万女性以激素替代疗法和口服避孕药的形式使用外源性孕激素,更好地了解孕酮在乳腺中的作用机制至关重要。

相似文献

1
Progesterone receptor isoforms in normal and malignant breast.正常和恶性乳腺组织中的孕激素受体亚型
Ernst Schering Found Symp Proc. 2007(1):77-107.
2
Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.孕激素受体亚型表达的改变重塑了乳腺癌细胞对孕激素的反应性。
Mol Endocrinol. 2005 Nov;19(11):2713-35. doi: 10.1210/me.2005-0126. Epub 2005 Jun 23.
3
Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activity.孕激素受体的局灶性亚核分布依赖配体,并与转录活性相关。
Mol Endocrinol. 2007 Jan;21(1):14-29. doi: 10.1210/me.2006-0041. Epub 2006 Oct 4.
4
Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.正常及恶性子宫内膜中孕激素受体A和B的亚核分布
J Clin Endocrinol Metab. 2004 Mar;89(3):1429-42. doi: 10.1210/jc.2003-031111.
5
Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts.
Breast Cancer Res Treat. 2004 Feb;83(3):211-20. doi: 10.1023/B:BREA.0000014041.58977.80.
6
Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.孕激素受体A过表达对乳腺癌细胞内源性孕激素敏感终点的影响。
Mol Endocrinol. 1999 Oct;13(10):1657-71. doi: 10.1210/mend.13.10.0356.
7
Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.子宫内膜样子宫内膜癌中孕激素受体A和B的相对表达
Cancer Res. 2001 Jun 1;61(11):4576-82.
8
Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.孕激素通过孕激素受体的B亚型在抗雌激素阻滞的乳腺癌细胞中重新启动细胞周期进程。
Cancer Res. 2007 Sep 15;67(18):8942-51. doi: 10.1158/0008-5472.CAN-07-1255.
9
Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.差异定量蛋白质组学揭示了与孕激素受体 A 表达的乳腺癌细胞表型变化相关的关键蛋白。
J Steroid Biochem Mol Biol. 2020 Apr;198:105560. doi: 10.1016/j.jsbmb.2019.105560. Epub 2019 Dec 3.
10
Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.孕激素受体A和B的协同表达缺失是乳腺癌发生过程中的早期事件。
Breast Cancer Res Treat. 2002 Mar;72(2):163-72. doi: 10.1023/a:1014820500738.

引用本文的文献

1
Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.肺癌中靶向核受体——新的治疗前景
Pharmaceuticals (Basel). 2022 May 18;15(5):624. doi: 10.3390/ph15050624.
2
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.I 期临床试验:一种 I 型抗孕激素药物——onapristone,在既往治疗后复发或转移性孕激素受体阳性的女性癌症患者中的应用。
PLoS One. 2018 Oct 10;13(10):e0204973. doi: 10.1371/journal.pone.0204973. eCollection 2018.
3
The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors.
在雌激素加孕激素激素治疗中,乳腺肿瘤对p27下调的增殖反应消失。
Transl Oncol. 2018 Apr;11(2):518-527. doi: 10.1016/j.tranon.2018.02.011. Epub 2018 Mar 7.
4
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.孕激素受体亚型比例:一种乳腺癌抗孕激素反应性的预后及预测因子
J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw317.
5
Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.携带BRCA1基因突变的女性正常乳腺组织中的细胞增殖及卵巢激素信号传导受损:孕激素受体调节剂治疗作为遗传性BRCA1基因突变女性乳腺癌预防策略的益处。
Oncotarget. 2016 Jul 19;7(29):45317-45330. doi: 10.18632/oncotarget.9638.
6
Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.醋酸乌利司他抑制孕激素受体A亚型介导的人乳腺癌增殖及Bcl-2-L1表达。
PLoS One. 2015 Oct 16;10(10):e0140795. doi: 10.1371/journal.pone.0140795. eCollection 2015.
7
Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System.孕酮与子宫肌层炎症的抑制:MKP-1和AP-1系统的作用
Mol Endocrinol. 2015 Oct;29(10):1454-67. doi: 10.1210/me.2015-1122. Epub 2015 Aug 17.
8
Divergent behavior of cyclin E and its low molecular weight isoforms to progesterone-induced growth inhibition in MCF-7 cells.细胞周期蛋白E及其低分子量亚型在MCF-7细胞中对孕酮诱导的生长抑制的不同行为。
Adv Biomed Res. 2015 Jan 6;4:16. doi: 10.4103/2277-9175.148299. eCollection 2015.
9
Progesterone action in breast, uterine, and ovarian cancers.孕酮在乳腺癌、子宫癌和卵巢癌中的作用。
J Mol Endocrinol. 2015 Apr;54(2):R31-53. doi: 10.1530/JME-14-0252. Epub 2015 Jan 13.
10
Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.乳腺癌中孕激素和抗孕激素反应性是由PRA/PRB比值通过AIB1或SMRT募集至CCND1和MYC启动子驱动的。
Int J Cancer. 2015 Jun 1;136(11):2680-92. doi: 10.1002/ijc.29304. Epub 2014 Nov 12.